Globalization: Another year closer to a worldwide network

John Carroll

When AstraZeneca announced its move to create its third R&D hub in China, the pharma giant was following in the paths of some major rivals. It also represented step to a more integrated biopharma world, creating a breeding ground for new company creation that stretches around the globe.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS